Stay updated on Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Minor UI/layout adjustments and some wording tweaks across sections like Study Overview and Study Plan; core content such as the study title, eligibility criteria, interventions, endpoints, and enrollment remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-02T00:56:49.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Upgraded to version v3.2.0 with a funding-status notice about operational limitations; v3.1.0 was removed. Indicates a maintenance/availability update rather than new content.
    Difference
    3%
    Check dated 2025-10-04T12:22:39.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Major addition of immunology-related terms and a version upgrade to v3.1.0; removal of the previous version v3.0.2.
    Difference
    0.9%
    Check dated 2025-09-27T07:59:22.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-13T01:46:29.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-05T19:56:52.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of various types of proteins and antibodies, as well as a new facility name and location. However, several previous terms related to antineoplastic agents and specific location details have been removed.
    Difference
    2%
    Check dated 2025-08-29T18:40:53.000Z thumbnail image

Stay in the know with updates to Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.